EP. 4 Dostarlimab Plus Chemotherapy for the Treatment of Advanced Endometrial Cancer: Data from the RUBY Trial
EP. 5 Data From the AtTEnd: Study: Atezolizumab Plus Carboplatin and Paclitaxel for Treatment of Advanced Endometrial Cancer
EP. 6 The Impact of Real-World Evidence on the Treatment of Patients With Advanced Endometrial Cancer
July 15th, 2026Pembrolizumab Monotherapy Improves PFS vs Chemotherapy in Frontline dMMR Endometrial CancerFirst-line pembrolizumab monotherapy met the primary end point of PFS in dMMR advanced/recurrent endometrial cancer.Read more